A high frequency of MDSCs in sepsis patients, with the granulocytic subtype dominating in gram-positive cases

Journal of Leukocyte Biology

Volumn 96, Issue 5, 2014, Pages 685-693

  Janols, Helena ^a,d   Bergenfelz, Caroline ^d   Allaoui, Roni ^d   Larsson, Anna Maria ^f   Rydén, Lisa ^b   Björnsson, Sven ^e   Janciauskiene, Sabina ^g   Wullt, Marlene ^a   Bredberg, Anders ^c   Leandersson, Karin ^d  

^a Departments of Infectious Diseases   (Sweden)

^b Departments of Surgery   (Sweden)

^c Departments of Medical Microbiology   (Sweden)

^d Center for Molecular Pathology   (Sweden)

^e LUND UNIVERSITY HOSPITAL   (Sweden)

^f LUND UNIVERSITY   (Sweden)

^g HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Cancer; CD11c; CD14; Ficoll; Granulocyte; MDSC

Indexed keywords

ANTIBIOTIC AGENT; CD11B ANTIGEN; CD14 ANTIGEN; CD15 ANTIGEN; CD33 ANTIGEN; FICOLL; HLA DR ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 6; INTERLEUKIN 8; REACTIVE OXYGEN METABOLITE; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; CYTOKINE; MEMBRANE ANTIGEN;

ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; BACTEREMIA; BLOOD; BLOOD SAMPLING; BONE MARROW CELL; BREAST CANCER; CELL POPULATION; CELL STRUCTURE; CITROBACTER KOSERI; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENSITY GRADIENT CENTRIFUGATION; ENTEROCOCCUS FAECALIS; ESCHERICHIA COLI; FEMALE; GRAM NEGATIVE SEPSIS; GRAM POSITIVE SEPSIS; GRANULOCYTE; HEPATITIS A; HEPATITIS B; HUMAN; HUMAN CELL; IMMATURITY; IN VITRO STUDY; INFLUENZA A; INFLUENZA A (H1N1); INFLUENZA B; KLEBSIELLA PNEUMONIAE; LEUKOCYTE COUNT; LYMPHOCYTE PROLIFERATION; MAJOR CLINICAL STUDY; MALE; MYELOID DERIVED SUPPRESSOR CELL; NONHUMAN; POLYMORPHONUCLEAR CELL; PROTEIN EXPRESSION; PROTEUS MIRABILIS; PSEUDOMONAS AERUGINOSA; SEPSIS; SEPTIC SHOCK; SERRATIA MARCESCENS; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS PNEUMONIAE; SUPPRESSOR CELL; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; BIOSYNTHESIS; GRAM POSITIVE INFECTION; IMMUNOLOGY; IMMUNOPHENOTYPING; LYMPHOCYTE ACTIVATION; METABOLISM; MICROBIOLOGY; MIDDLE AGED; PHENOTYPE; T LYMPHOCYTE SUBPOPULATION; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, SURFACE; CYTOKINES; FEMALE; GRAM-POSITIVE BACTERIAL INFECTIONS; GRANULOCYTES; HUMANS; IMMUNOPHENOTYPING; LEUKOCYTE COUNT; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; MYELOID CELLS; PHENOTYPE; SEPSIS; T-LYMPHOCYTE SUBSETS; YOUNG ADULT;

EID: 84908289124     PISSN: 07415400     EISSN: 19383673     Source Type: Journal    
DOI: 10.1189/jlb.5HI0214-074R     Document Type: Article

References (25)

1. Cuenca, A. G., Delano, M. J., Kelly-Scumpia, K. M., Moreno, C., Scumpia, P. O., Laface, D. M., Heyworth, P. G., Efron, P. A., Moldawer, L. L. (2011) A paradoxical role for myeloid-derived suppressor cells in sepsis and trauma. Mol. Med. 17, 281–292.
2. Filipazzi, P., Huber, V., Rivoltini, L. (2012) Phenotype, function and clinical implications of myeloid-derived suppressor cells in cancer patients. Cancer Immunol. Immunother. 61, 255–263.
3. Peranzoni, E., Zilio, S., Marigo, I., Dolcetti, L., Zanovello, P., Mandruzzato, S., Bronte, V. (2010) Myeloid-derived suppressor cell heterogeneity and subset definition. Curr. Opin. Immunol. 22, 238–244.
4. Poschke, I., Kiessling, R. (2012) On the armament and appearances of human myeloid-derived suppressor cells. Clin. Immunol. 144, 250–268.
5. Greifenberg, V., Ribechini, E., Rossner, S., Lutz, M. B. (2009) Myeloidderived suppressor cell activation by combined LPS and IFN-γ treatment impairs DC development. Eur. J. Immunol. 39, 2865–2876.
6. Rodrigues, J. C., Gonzalez, G. C., Zhang, L., Ibrahim, G., Kelly, J. J., Gustafson, M. P., Lin, Y., Dietz, A. B., Forsyth, P. A., Yong, V. W., et al. (2010) Normal human monocytes exposed to glioma cells acquire myeloid- derived suppressor cell-like properties. Neurooncology 12, 351–365.
7. Umansky, V., Sevko, A. (2013) Tumor microenvironment and myeloidderived suppressor cells. Cancer Microenviron. 6, 169–177.
8. Poschke, I., Mougiakakos, D., Hansson, J., Masucci, G. V., Kiessling, R. (2010) Immature immunosuppressive CD14+HLA-DR_/low cells in melanoma patients are Stat3hi and overexpress CD80, CD83, and DCsign. Cancer Res. 70, 4335–4345.
9. Mandruzzato, S., Solito, S., Falisi, E., Francescato, S., Chiarion-Sileni, V., Mocellin, S., Zanon, A., Rossi, C. R., Nitti, D., Bronte, V., et al. (2009) IL4Rα+ myeloid-derived suppressor cell expansion in cancer patients. J. Immunol. 182, 6562–6568.
10. Almand, B., Clark, J. I., Nikitina, E., van Beynen, J., English, N. R., Knight, S. C., Carbone, D. P., Gabrilovich, D. I. (2001) Increased production of immature myeloid cells in cancer patients: a mechanism of immunosuppression in cancer. J. Immunol. 166, 678–689.
11. Denny, M. F., Yalavarthi, S., Zhao, W., Thacker, S. G., Anderson, M., Sandy, A. R., McCune, W. J., Kaplan, M. J. (2010) A distinct subset of proinflammatory neutrophils isolated from patients with systemic lupus erythematosus induces vascular damage and synthesizes type I IFNs. J. Immunol. 184, 3284–3297.
12. Hacbarth, E., Kajdacsy-Balla, A. (1986) Low density neutrophils in patients with systemic lupus erythematosus, rheumatoid arthritis, and acute rheumatic fever. Arthritis Rheum. 29, 1334–1342.
13. Slivinskii, G. G., Il’iasova, M. N., Kozhanova, S. V. (1987) [Electrophoretic heterogeneity of peripheral blood granulocytes in patients with chronic myeloid leukemia]. Eksp. Onkol. 9, 67–70.
14. Bone, R. C., Balk, R. A., Cerra, F. B., Dellinger, R. P., Fein, A. M., Knaus, W. A., Schein, R. M., Sibbald, W. J. (1992) Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 101, 1644–1655.
15. Meyer, T. P., Zehnter, I., Hofmann, B., Zaisserer, J., Burkhart, J., Rapp, S., Weinauer, F., Schmitz, J., Illert, W. E. (2005) Filter buffy coats (FBC): a source of peripheral blood leukocytes recovered from leukocyte depletion filters. J. Immunol. Methods 307, 150–166.
16. Janols, H., Wullt, M., Bergenfelz, C., Bjornsson, S., Lickei, H., Janciauskiene, S., Leandersson, K., Bredberg, A. (2014) Heterogeneity among septic shock patients in a set of immunoregulatory markers. Eur. J. Clin. Microbiol. Infect. Dis. 33, 313–324.
17. Bergenfelz, C., Medrek, C., Ekstrom, E., Jirstrom, K., Janols, H., Wullt, M., Bredberg, A., Leandersson, K. (2012) Wnt5a induces a tolerogenic phenotype of macrophages in sepsis and breast cancer patients. J. Immunol. 188, 5448–5458.
18. Bergenfelz, C., Janols, H., Wullt, M., Jirstrom, K., Bredberg, A., Leandersson, K. (2013) Wnt5a inhibits human monocyte-derived myeloid dendritic cell generation. Scand. J. Immunol. 78, 194–204.
19. Ng, P. C., Lam, H. S. (2006) Diagnostic markers for neonatal sepsis. Curr. Opin. Pediatr. 18, 125–131.
20. Hirsh, M., Mahamid, E., Bashenko, Y., Hirsh, I., Krausz, M. M. (2001) Overexpression of the high-affinity Fcγ receptor (CD64) is associated with leukocyte dysfunction in sepsis. Shock 16, 102–108.
21. Pillay, J., Kamp, V. M., van Hoffen, E., Visser, T., Tak, T., Lammers, J. W., Ulfman, L. H., Leenen, L. P., Pickkers, P., Koenderman, L. (2012) A subset of neutrophils in human systemic inflammation inhibits T cell responses through Mac-1. J. Clin. Invest. 122, 327–336.
22. Drifte, G., Dunn-Siegrist, I., Tissieres, P., Pugin, J. (2013) Innate immune functions of immature neutrophils in patients with sepsis and severe systemic inflammatory response syndrome. Crit. Care Med. 41, 820–832.
23. Pilz, G. A., Braun, J., Ulrich, C., Felka, T., Warstat, K., Ruh, M., Schewe, B., Abele, H., Larbi, A., Aicher, W. K. (2011) Human mesenchymal stromal cells express CD14 cross-reactive epitopes. Cytometry A 79, 635–645.
24. Ray, A., Chakraborty, K., Ray, P. (2013) Immunosuppressive MDSCs induced by TLR signaling during infection and role in resolution of inflammation. Front. Cell. Infect. Microbiol. 3, 52.
25. Ward, N. S., Casserly, B., Ayala, A. (2008) The compensatory anti-inflammatory response syndrome (CARS) in critically ill patients. Clin. Chest Med. 29, 617–625.